Reply to "use of Unenhanced MR Lymphography to Characterize Lung Lymphatic Diseases".

Xuguang Sun,Rengui Wang

DOI: https://doi.org/10.2214/ajr.17.18101

2017-01-01

American Journal of Roentgenology

Abstract:Reply to “Use of Unenhanced MR Lymphography to Characterize Lung Lymphatic Diseases” We agree with Arrivé et al. [1] that unenhanced MR lymphography with very heavily T2-weighted sequences allows the precise evaluation of lymphatic abnormalities and reveals peribronchovascular thickening, ground-glass opacities, and soft-tissue infiltration. Associated abnormalities, such as axillary or cervical cystic lymphangiomas, splenic cystic lymphangiomas, and lymph node abnormalities, which are very commonly observed in patients with diffuse pulmonary lymphangiomatosis, may also be seen with unenhanced MR lymphography [2]. In addition, MR lymphography based on heavily T2-weighted fast spin-echo sequences is a useful noninvasive technique [3, 4]. In our study [5], direct lymphangiography of the lower extremities was performed by an experienced surgeon on a digital subtraction angiography unit using standard techniques. A total of 8–10 mL of iodinated oil injection was administered at a rate of 4–6 mL/h via the patient’s normal unilateral dorsal lymphatic vessel. During the injection, iodinated oil flowing through lower limb lymphatic vessels, iliac lymphatic vessels, lumbar trunk, and thoracic duct was dynamically observed on the digital subtraction angiogram [5]. Direct lymphangiography is an invasive technique, and MDCT performed after direct lymphangiography involves radiation. MR lymphography has the important benefit of not using ionizing radiation. It also offers the significant advantage of permitting dynamic monitoring of lymphatic transit, especially on high-resolution sequential 3D imaging of the thorax and abdomen. However, the quality of MRI performed after thoracic angiography is relatively poor because of respiratory motion artifacts [6]. It is worth noting that MDCT can be applied for evaluation of lymphatic vessels after direct lymphangiography, whereas unenhanced MR lymphography cannot distinguish lymph from water because of their high signals on heavily T2weighted sequences. Therefore, we believe that both MRI and MDCT are great imaging modalities with their own unique strengths for the diagnosis of lymphatic diseases. However, during clinical routine practice, physicians may encounter various conditions, including, but not limited to, the specific disease discussed in our article [5]. MDCT lymphangiography enables faster acquisition of high-resolution images in a wide range and, thus, shows a unique advantage during the differentiation of various diseases. In addition, the thoracic MR image quality may be compromised occasionally by artifacts due to respiratory motion, which is one of the factors motivating us to focus on the MDCT lymphangiography technique. However, MR lymphangiography, with its strengths of being noninvasive and radiation free, will have great application as the techniques advance. We sincerely appreciate the comments of the readers. Xiaoli Sun Rengui Wang Beijing Shijitan Hospital, Capital Medical University Beijing, China 490150302@qq.com DOI:10.2214/AJR.17.18101 WEB—This is a web exclusive article.